{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:09:19Z","timestamp":1772172559246,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1007147","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000}}],"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1007147","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T13:35:45Z","timestamp":1583156145000},"page":"e1007147","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell lines"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2790-6668","authenticated-orcid":true,"given":"Elba","family":"Raim\u00fandez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwen","family":"Zwingenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-0191","authenticated-orcid":true,"given":"Karolin","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1736-9096","authenticated-orcid":true,"given":"Sabine","family":"Hug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2419-1943","authenticated-orcid":true,"given":"Fabian J.","family":"Theis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6900-0944","authenticated-orcid":true,"given":"Birgit","family":"Luber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4935-3312","authenticated-orcid":true,"given":"Jan","family":"Hasenauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"pcbi.1007147.ref001","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","author":"F Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"pcbi.1007147.ref002","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ctrv.2014.03.002","article-title":"Unmet needs and challenges in gastric cancer: the way forward","volume":"40","author":"F Lordick","year":"2014","journal-title":"Cancer Treat Rev"},{"issue":"9742","key":"pcbi.1007147.ref003","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"YJ Bang","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"pcbi.1007147.ref004","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(13)70102-5","article-title":"Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial","volume":"14","author":"F Lordick","year":"2013","journal-title":"Lancet Oncol"},{"issue":"4","key":"pcbi.1007147.ref005","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ccr.2005.03.003","article-title":"Structural basis for inhibition of the epidermal growth factor receptor by cetuximab","volume":"7","author":"S Li","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"pcbi.1007147.ref006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41540-017-0030-3","article-title":"Predicting ligand-dependent tumors from multi-dimensional signaling features","volume":"3","author":"H Hass","year":"2017","journal-title":"npj Syst Biol Appl"},{"key":"pcbi.1007147.ref007","article-title":"EGF receptor ligands: recent advances","author":"B Singh","year":"2016","journal-title":"F1000 Research"},{"key":"pcbi.1007147.ref008","article-title":"Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity","author":"M Hara","year":"2008","journal-title":"Cancer Science"},{"issue":"1","key":"pcbi.1007147.ref009","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1186\/s12885-017-3822-3","article-title":"Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis","volume":"17","author":"S Keller","year":"2017","journal-title":"BMC Cancer"},{"key":"pcbi.1007147.ref010","article-title":"Bring on the biomarkers","author":"G Poste","year":"2011","journal-title":"Nature"},{"issue":"7391","key":"pcbi.1007147.ref011","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"J Barretina","year":"2012","journal-title":"Nature"},{"issue":"Database issue","key":"pcbi.1007147.ref012","first-page":"D955","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"W Yang","year":"2013","journal-title":"Nucl Acids Res"},{"issue":"408","key":"pcbi.1007147.ref013","doi-asserted-by":"crossref","first-page":"fs21","DOI":"10.1126\/scisignal.aad4989","article-title":"Beyond static biomarkers\u2014The dynamic response potential of signaling networks as an alternate biomarker?","volume":"8","author":"J Kim","year":"2015","journal-title":"Sci Signal"},{"issue":"408","key":"pcbi.1007147.ref014","article-title":"Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients","volume":"8","author":"D Fey","year":"2015","journal-title":"Sci Signal"},{"issue":"6","key":"pcbi.1007147.ref015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cels.2018.10.013","article-title":"Efficient parameter estimation enables the prediction of drug response using a mechanistic pan-cancer pathway model","volume":"7","author":"F Fr\u00f6hlich","year":"2018","journal-title":"Cell Systems"},{"issue":"Database issue","key":"pcbi.1007147.ref016","doi-asserted-by":"crossref","first-page":"D355","DOI":"10.1093\/nar\/gkp896","article-title":"KEGG for representation and analysis of molecular networks involving diseases and drugs","volume":"38","author":"M Kanehisa","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"pcbi.1007147.ref017","doi-asserted-by":"crossref","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","article-title":"Reactome: A database of reactions, pathways and biological processes","volume":"39","author":"D Croft","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1007147.ref018","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1752-0509-4-92","article-title":"BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models","volume":"4","author":"C Li","year":"2010","journal-title":"BMC Syst Biol"},{"key":"pcbi.1007147.ref019","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ncb1233","article-title":"Prediction and validation of the distinct dynamics of transient and sustained ERK activation","volume":"7","author":"S Sasagawa","year":"2005","journal-title":"Nat Cell Biol"},{"issue":"77","key":"pcbi.1007147.ref020","first-page":"ra31","article-title":"Therapeutically targeting ErbB3: A key node in ligand-induced activation of the ErbB receptor\u2013PI3K axis","volume":"2","author":"B Sch\u00f6berl","year":"2009","journal-title":"Science Signaling"},{"issue":"132","key":"pcbi.1007147.ref021","doi-asserted-by":"crossref","first-page":"ra56","DOI":"10.1126\/scisignal.2000810","article-title":"Decoupling of receptor and downstream signals in the Akt pathway by its low-pass filter characteristics","volume":"3","author":"KA Fujita","year":"2010","journal-title":"Sci Signal"},{"key":"pcbi.1007147.ref022","article-title":"Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling","author":"A Flobak","year":"2015","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"pcbi.1007147.ref023","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1214\/aos\/1176344136","article-title":"Estimating the dimension of a model","volume":"6","author":"G Schwarz","year":"1978","journal-title":"Ann Statist"},{"issue":"2","key":"pcbi.1007147.ref024","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3892\/ijo.2012.1479","article-title":"Association of amphiregulin with the cetuximab sensitivity of gastric cancer cell lines","volume":"41","author":"J Kneissl","year":"2012","journal-title":"Int J Oncol"},{"key":"pcbi.1007147.ref025","article-title":"HGVS Recommendations for the Description of Sequence Variants: 2016 Update","author":"J den Dunnen","year":"2016","journal-title":"Hum Mutat"},{"issue":"3","key":"pcbi.1007147.ref026","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1073\/pnas.0408864102","article-title":"Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic","volume":"102","author":"S Kang","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2005.0010","key":"pcbi.1007147.ref027","article-title":"A comprehensive pathway map of epidermal growth factor receptor signaling","volume":"1","author":"K Oda","year":"2005","journal-title":"Mol Syst Biol"},{"issue":"6","key":"pcbi.1007147.ref028","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1357-2725(99)00015-1","article-title":"EGF receptor","volume":"31","author":"A Wells","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"pcbi.1007147.ref029","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4161\/cbt.23627","article-title":"Mechanisms of resistance to EGFR targeted therapies","volume":"14","author":"G Hrustanovic","year":"2013","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"pcbi.1007147.ref030","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.18632\/oncotarget.14012","article-title":"Mechanisms of resistance to anti-EGFR therapy in colorectal cancer","volume":"8","author":"B Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"pcbi.1007147.ref031","doi-asserted-by":"crossref","first-page":"e74335","DOI":"10.1371\/journal.pone.0074335","article-title":"Lessons learned from quantitative dynamical modeling in systems biology","volume":"8","author":"A Raue","year":"2013","journal-title":"PLoS ONE"},{"issue":"21","key":"pcbi.1007147.ref032","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1093\/bioinformatics\/btv405","article-title":"Data2Dynamics: a modeling environment tailored to parameter estimation in dynamical systems","volume":"31","author":"A Raue","year":"2015","journal-title":"Bioinformatics"},{"issue":"15","key":"pcbi.1007147.ref033","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/bioinformatics\/btw131","article-title":"Analysis of CFSE time-series data using division-, age- and label-structured population models","volume":"32","author":"S Hross","year":"2016","journal-title":"Bioinformatics"},{"issue":"17","key":"pcbi.1007147.ref034","doi-asserted-by":"crossref","first-page":"i718","DOI":"10.1093\/bioinformatics\/btw461","article-title":"L1 regularization facilitates detection of cell type-specific parameters in dynamical systems","volume":"32","author":"B Steiert","year":"2016","journal-title":"Bioinformatics"},{"key":"pcbi.1007147.ref035","article-title":"Relevance of MET activation and genetic alterations of KRAS and E-cadherin for cetuximab sensitivity of gastric cancer cell lines","author":"S Heindl","year":"2012","journal-title":"J Cancer Res Clin Oncol"},{"key":"pcbi.1007147.ref036","article-title":"Negative feedback regulation of the ERK1\/2 MAPK pathway","author":"D Lake","year":"2016","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"10","key":"pcbi.1007147.ref037","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1371\/journal.pcbi.0030189","article-title":"Universally sloppy parameter sensitivities in systems biology models","volume":"3","author":"RN Gutenkunst","year":"2007","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1007147.ref038","article-title":"Novel c-Met inhibitor suppresses the growth of c-Met-addicted gastric cancer cells","author":"CH Park","year":"2016","journal-title":"BMC Cancer"},{"issue":"16","key":"pcbi.1007147.ref039","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1158\/1078-0432.CCR-16-2738","article-title":"PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer","volume":"23","author":"JM Xu","year":"2017","journal-title":"Clin Cancer Res"},{"key":"pcbi.1007147.ref040","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s12885-016-2422-y","article-title":"Prognostic and clinical impact of PIK3CA mutation in gastric cancer: pyrosequencing technology and literature review","volume":"16","author":"K Harada","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"pcbi.1007147.ref041","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/atm.2016.12.33","article-title":"MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy","volume":"5","author":"S Pilotto","year":"2017","journal-title":"Ann Transl Med"},{"key":"pcbi.1007147.ref042","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1038\/srep02992","article-title":"A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy","volume":"3","author":"L Zhang","year":"2013","journal-title":"Sci Rep"},{"issue":"1","key":"pcbi.1007147.ref043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2008.11.008","article-title":"Functional selectivity of EGF family peptide growth factors: implications for cancer","volume":"122","author":"KJ Wilson","year":"2009","journal-title":"Pharmacol Ther"},{"issue":"38","key":"pcbi.1007147.ref044","doi-asserted-by":"crossref","first-page":"26178","DOI":"10.1074\/jbc.M114.586826","article-title":"Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation","volume":"289","author":"JL Macdonald-Obermann","year":"2014","journal-title":"J Biol Chem"},{"key":"pcbi.1007147.ref045","article-title":"Differential effects of EGFR ligands on endocytic sorting of the receptor","author":"K Roepstorff","year":"2009","journal-title":"Traffic"},{"key":"pcbi.1007147.ref046","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1038\/oncsis.2015.19","article-title":"Atlas of Cancer Signalling Network: A systems biology resource for integrative analysis of cancer data with Google Maps","volume":"4","author":"I Kuperstein","year":"2015","journal-title":"Oncogenesis"},{"key":"pcbi.1007147.ref047","article-title":"NIH Image to ImageJ: 25 years of image analysis","author":"CA Schneider","year":"2012","journal-title":"Nature methods"},{"key":"pcbi.1007147.ref048","first-page":"bty736","article-title":"Benchmarking optimization methods for parameter estimation in large kinetic models","author":"AF Villaverde","year":"2018","journal-title":"Bioinformatics"},{"key":"pcbi.1007147.ref049","first-page":"btz020","article-title":"Benchmark Problems for Dynamic Modeling of Intracellular Processes","author":"H Hass","year":"2019","journal-title":"Bioinformatics"},{"issue":"26","key":"pcbi.1007147.ref050","first-page":"63","article-title":"New Concepts for Evaluating the Performance of Computational Methods","volume":"49","author":"C Kreutz","year":"2016","journal-title":"IFAC-PapersOnLine"},{"key":"pcbi.1007147.ref051","volume-title":"Model selection and multimodel inference: A practical information-theoretic approach","author":"KP Burnham","year":"2002"},{"issue":"11","key":"pcbi.1007147.ref052","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1111\/febs.12276","article-title":"Profile likelihood in systems biology","volume":"280","author":"C Kreutz","year":"2013","journal-title":"FEBS J"},{"issue":"4","key":"pcbi.1007147.ref053","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/bioinformatics\/btx676","article-title":"PESTO: Parameter EStimation TOolbox","volume":"34","author":"P Stapor","year":"2018","journal-title":"Bioinformatics"},{"issue":"24","key":"pcbi.1007147.ref054","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1093\/bioinformatics\/bty514","article-title":"Hierarchical optimization for the efficient parametrization of ODE models","volume":"34","author":"C Loos","year":"2018","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1007147","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T00:00:00Z","timestamp":1583971200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T13:56:43Z","timestamp":1584021403000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1007147"}},"subtitle":[],"editor":[{"given":"James","family":"Gallo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1007147","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/656967","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]}}}